New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 3, 2014
08:12 EDTABMDAbiomed surpasses 20,000 U.S. Impella patients
Abiomed reported that physicians have implanted more than 20,000 Impella pumps in U.S. patients requiring hemodynamic support. To date, the higher flow Impella CP has been implanted in over 3,000 U.S. patients, the company noted. The Impella RP recently received CE Marking approval in the European Union and also completed patient enrollment in its Investigational Device Exemption trial, RECOVER RIGHT, with an extended Continuous Access Protocol to allow the company to continue enrolling an additional 22 patients into the trial for further evaluation. FDA approval for the Impella RP is expected by early 2015, Abiomed said.
News For ABMD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 24, 2015
16:20 EDTABMDOn The Fly: Closing Wrap
Subscribe for More Information
12:44 EDTABMDOn The Fly: Midday Wrap
Subscribe for More Information
11:04 EDTABMDAbiomed retraces gains, levels to watch
Subscribe for More Information
09:22 EDTABMDOn The Fly: Pre-market Movers
Subscribe for More Information
March 23, 2015
19:13 EDTABMDOn The Fly: After Hours Movers
Subscribe for More Information
17:47 EDTABMDAbiomed confirms FDA approval of Impella 2.5 heart pump
Subscribe for More Information
17:17 EDTABMDFDA approves Impella 2.5 System
The U.S. FDA approved the Impella 2.5 System, a miniature blood pump system intended to help certain patients maintain stable heart function and circulation during certain high-risk percutaneous coronary intervention procedures, such as balloon angioplasty and stenting, which re-open coronary arteries that are narrowed or blocked due to severe coronary artery disease. The Impella 2.5 System is manufactured by Abiomed, based in Danvers, Massachusetts. Reference Link
March 19, 2015
07:17 EDTABMDStephens to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use